SCHEMBL14919007

SCHEMBL14919007

COC(C)OC(=O)c1ccncc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
HSD17B10 Q99714 1/20 0.48
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
PTGS2 P35354 1/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
CA14 Q9ULX7 1/20 0.43
NAPRT Q6XQN6 1/20 0.42
POLB P06746 1/20 0.41
KMT2A Q03164 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
ADRB2 P07550 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15953934 0.90 HSD17B10 (0.53) LMNACYP1A2CYP2C9CYP2C19SMN1; SMN2
SCHEMBL17797792 0.86 CA1 (0.55) LMNASMN1; SMN2CA12CA1CA2
SCHEMBL26123689 0.83 LMNA (0.51) LMNACYP1A2CYP2C9CYP2C19SMN1; SMN2
Isopropyl Isonicotinate SCHEMBL552612 0.82 CA12 (0.62) LMNACYP1A2CYP2C9CYP2C19SMN1; SMN2
SCHEMBL28927209 0.81 CA1 (0.55) CA12CA1CA2CA7CA9
Isopropyl Isonicotinate SCHEMBL30827702 0.81 CA12 (0.60) LMNACYP1A2CYP2C9CYP2C19SMN1; SMN2
SCHEMBL4418738 0.81 TSHR (0.57) LMNACYP1A2SMN1; SMN2HSD17B10CA12
SCHEMBL5363067 0.80 ALDH1A1 (0.65) LMNAHSD17B10POLBKMT2AALDH1A1
SCHEMBL3015986 0.79 HSD17B10 (0.50) LMNACYP1A2CYP2C9CYP2C19SMN1; SMN2
SCHEMBL9004307 0.79 CA1 (0.48) LMNACYP2C9CYP2C19SMN1; SMN2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2595989-A1 HETEROCYCLIC CHROMENE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS Vertex Pharmaceuticals Incorporated (US) 2013-05-29 EP disclosed
WO-2013067248-A1 BENZOXAZINES AS MODULATORS OF ION CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-05-10 WO disclosed